Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
27
Filosofía
14
Libre albedrío y determinismo
10
Jazz
9
Música popular
9
Aspectos económicos
8
Sociología
8
Etnología
7
Comercio
6
Aspectos psicológicos
5
Aspectos sociales
5
Cambio social
5
Ciudades y pueblos
5
Libre comercio
5
Modelos matemáticos
5
Política económica
5
Política gubernamental
5
Abuso de drogas
4
Administración
4
Ciencias sociales
4
Condiciones sociales
4
Democracia
4
Educación
4
Filosofía de la mente
4
History
4
Inglés
4
Mercadotecnia
4
Política y gobierno
4
Sistemas operativos (Computadoras)
4
Urbanismo
4
-
483941por Yao, Ji-Jin, Zhou, Guan-Qun, Wang, Ya-Qin, Wang, Si-Yang, Zhang, Wang-Jian, Jin, Ya-Nan, Zhang, Fan, Li, Li, Liu, Li-Zhi, Cheng, Zhi-Bin, Ma, Jun, Qi, Zhen-Yu, Sun, Ying“…RESULTS: The 5-year distant metastasis-free survival (DMFS) rates for patients with GTVnd > 18.9 vs. ≤ 18.9 mL were 82.2% vs. 93.2% (P < 0.001), and for patients with EBV DNA copy number > 4000 vs. ≤ 4000 copies/mL were 83.5% vs. 93.9% (P < 0.001). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483942por Seibert, Tyler M, Fan, Chun Chieh, Wang, Yunpeng, Zuber, Verena, Karunamuni, Roshan, Parsons, J Kellogg, Eeles, Rosalind A, Easton, Douglas F, Kote-Jarai, ZSofia, Al Olama, Ali Amin, Garcia, Sara Benlloch, Muir, Kenneth, Grönberg, Henrik, Wiklund, Fredrik, Aly, Markus, Schleutker, Johanna, Sipeky, Csilla, Tammela, Teuvo LJ, Nordestgaard, Børge G, Nielsen, Sune F, Weischer, Maren, Bisbjerg, Rasmus, Røder, M Andreas, Iversen, Peter, Key, Tim J, Travis, Ruth C, Neal, David E, Donovan, Jenny L, Hamdy, Freddie C, Pharoah, Paul, Pashayan, Nora, Khaw, Kay-Tee, Maier, Christiane, Vogel, Walther, Luedeke, Manuel, Herkommer, Kathleen, Kibel, Adam S, Cybulski, Cezary, Wokolorczyk, Dominika, Kluzniak, Wojciech, Cannon-Albright, Lisa, Brenner, Hermann, Cuk, Katarina, Saum, Kai-Uwe, Park, Jong Y, Sellers, Thomas A, Slavov, Chavdar, Kaneva, Radka, Mitev, Vanio, Batra, Jyotsna, Clements, Judith A, Spurdle, Amanda, Teixeira, Manuel R, Paulo, Paula, Maia, Sofia, Pandha, Hardev, Michael, Agnieszka, Kierzek, Andrzej, Karow, David S, Mills, Ian G, Andreassen, Ole A, Dale, Anders M“…The hazard score was calculated for these men to test prediction of survival free from PCa. SETTING: Multiple institutions that were members of international PRACTICAL consortium. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483943“…The remaining 40 patients were included in this analysis of presenting parameters with respect to R0 resection, disease‐free survival (DFS), and overall survival (OS). R0 resection was achieved in 28 of 40 patients (70%), and R1 resection in the remaining 12 (30%). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483944por Hungerford, Daniel, Vivancos, Roberto, Read, Jonathan M., Iturriza-Gόmara, Miren, French, Neil, Cunliffe, Nigel A.“…The UK introduced the monovalent rotavirus vaccine (Rotarix®) in July 2013. Vaccination is free of charge to parents, with two doses delivered at 8 and 12 weeks of age. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483945por Xiao, Xiao, Putatunda, Raj, Zhang, Yonggang, Soni, Priya V., Li, Fang, Zhang, Ting, Xin, Mingyang, Luo, Jin Jun, Bethea, John R., Cheng, Yuan, Hu, Wenhui“…METHODS: The C57BL/6J wild-type and GFAP-dnIκBα transgenic mice were used. Serum-free embryoid bodies were cultured from mouse embryonic stem cells and further induced into neural stem/progenitor cells (NSCs/NPCs). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483946por Janssen, Martin W. W., Linxweiler, Johannes, Philipps, Ines, Bütow, Zentia, Siemer, Stefan, Stöckle, Michael, Ohlmann, Carsten-Henning“…At follow-up (median follow-up of 83.5 ± 40.7 months), six patients had died (50%)—all with functioning grafts (free from hemodialysis). In five cases, recurrence of primary tumor or metastatic disease was recorded. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483947por Hong, Danping, Ding, Jiongyan, Li, Ouyang, He, Quan, Ke, Minxia, Zhu, Mengyi, Liu, Lili, Ou, Wen-Bin, He, Yulong, Wu, Yuehong“…METHODS: In the present study, macrophages derived from hiPS were established via embryoid body (EB) formation by using feeder-free culture conditions, and the human monocyte cell line THP-1 (THP-1-Mφ) was used as control. iPS-Mφ were characterized by using morphology, Giemsa staining, nonspecific esterase staining (α-NAE), phagocytosis, and surface phenotype. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483948por Conteduca, V., Wetterskog, D., Sharabiani, M. T. A., Grande, E., Fernandez-Perez, M. P., Jayaram, A., Salvi, S., Castellano, D., Romanel, A., Lolli, C., Casadio, V., Gurioli, G., Amadori, D., Font, A., Vazquez-Estevez, S., González del Alba, A., Mellado, B., Fernandez-Calvo, O., Méndez-Vidal, M. J., Climent, M. A., Duran, I., Gallardo, E., Rodriguez, A., Santander, C., Sáez, M. I., Puente, J., Gasi Tandefelt, D., Wingate, A., Dearnaley, D., Demichelis, F., De Giorgi, U., Gonzalez-Billalabeitia, E., Attard, G.“…We evaluated associations between plasma AR and overall survival (OS) and progression-free survival (PFS) in 73 chemotherapy-naïve and 98 post-docetaxel CRPC patients treated with enzalutamide or abiraterone (Primary cohort) and 94 chemotherapy-naïve patients treated with enzalutamide (Secondary cohort; PREMIERE trial). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483949por Nieto, Yago, Valdez, Benigno C, Pingali, Sai R, Bassett, Roland, Delgado, Ruby, Nguyen, John, Shah, Nina, Popat, Uday, Jones, Roy B, Andersson, Borje S, Gulbis, Alison, Ahmed, Sairah, Bashir, Qaiser, Parmar, Simrit, Patel, Krina, Myers, Alan, Rondon, Gabriela, Orlowski, Robert Z, Champlin, Richard, Qazilbash, Muzaffar“…Gem/Bu/Mel resulted in improved progression-free survival (median 15.1 v 9.3 months, P=0.0030; hazard ratio=0.60; P=0.021) and overall survival (median 37.5 v 23 months, P=0.0092; hazard ratio=0.65, P=0.0087). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483950por Lathrop, Eva, Romero, Lisa, Hurst, Stacey, Bracero, Nabal, Zapata, Lauren B, Frey, Meghan T, Rivera, Maria I, Berry-Bibee, Erin N, Honein, Margaret A, Monroe, Judith, Jamieson, Denise J“…As part of a Z-CAN programme monitoring plan, participants were invited to complete a patient satisfaction survey about whether they had obtained free, same-day access to their chosen contraceptive method after receiving comprehensive counselling, their perception of the quality of care they had received, and their satisfaction with their chosen method and services. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483951por Karmali, Kunal N., Lloyd-Jones, Donald M., van der Leeuw, Joep, Goff, David C., Yusuf, Salim, Zanchetti, Alberto, Glasziou, Paul, Jackson, Rodney, Woodward, Mark, Rodgers, Anthony, Neal, Bruce C., Berge, Eivind, Teo, Koon, Davis, Barry R., Chalmers, John, Pepine, Carl, Rahimi, Kazem, Sundström, JohanEnlace del recurso
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483952por Myer, Landon, Phillips, Tamsin K., Zerbe, Allison, Brittain, Kirsty, Lesosky, Maia, Hsiao, Nei-Yuan, Remien, Robert H., Mellins, Claude A., McIntyre, James A., Abrams, Elaine J.“…For the infants, overall HIV-free survival through 12 months of age was 97%: mother-to-child HIV transmission was 1.2% overall (n = 4 and n = 1 transmissions in the intervention and control arms, respectively), and infant mortality was 1.9% (n = 6 and n = 3 deaths in the intervention and control arms, respectively), and these outcomes were similar by trial arm. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483953por Huet, Sarah, Tesson, Bruno, Jais, Jean-Philippe, Feldman, Andrew L, Magnano, Laura, Thomas, Emilie, Traverse-Glehen, Alexandra, Albaud, Benoit, Carrère, Marjorie, Xerri, Luc, Ansell, Stephen M, Baseggio, Lucile, Reyes, Cécile, Tarte, Karin, Boyault, Sandrine, Haioun, Corinne, Link, Brian K, Feugier, Pierre, Lopez-Guillermo, Armando, Tilly, Hervé, Brice, Pauline, Hayette, Sandrine, Jardin, Fabrice, Offner, Fritz, Sujobert, Pierre, Gentien, David, Viari, Alain, Campo, Elias, Cerhan, James R, Salles, Gilles“…In a retrospectively assembled training cohort of 134 pretreatment FL patients from the prospective randomized PRIMA trial, we developed an expression-based predictor of progression-free survival (PFS) that was further evaluated in FFPE samples obtained from three independent international cohorts, using NanoString technology. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483954por McGorry, Patrick, Francey, Shona, Nelson, Barnaby, Jessica, Graham, Lara, Baldwin, Suzy, Harrigan, Pan Yuen, Hok, Alex, Fornito, Kelly, Allott, Mario, Alvarez-Jimenez, Brian, O’Donoghoe“…DISCUSSION: The results of this study demonstrate that it is feasible and acceptable to conduct AP-free research in carefully selected FEP to examine the risk-benefit ratio of current treatments under carefully controlled conditions that prioritise patient outcomes and safety. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483955por van Amelsvoort, Therese, Bakker, Geor, Vingerhoets, Claudia, Sahakian, Barbara J, Bloemen, Oswald, Caan, Matthan, Booij, Jan“…Therefore, the current study sought to examine alterations in muscarinic M1 receptor signaling in relation to cognitive functioning in medication free subjects with psychotic disorders and matched controls. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483956por Porffy, Lilla, Wigton, Rebekah, Coutrot, Antoine, Joyce, Dan, Mareschal, Isabelle, Shergill, Sukhi“…Participants engaged in a free-viewing eye-tracking task, during which they were looking at 6 facial images of two Caucasian men displaying angry, happy, and neutral facial expressions, and 6 control images in a random order. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483957por Iversen, Trude, Steen, Nils E, Birkeland, Kåre I, Mørch, Ragni H, Reponen, Elina J, Anderssen, Jannicke F, Rødevand, Linn, Melle, Ingrid, Andreassen, Ole A, Molden, Espen, Jönsson, Erik“…BACKGROUND: Altered levels of free Thyroxin (fT4) and Thyroid Stimulating Hormone (TSH) have been associated with severe mental disorders and the use of antipsychotic drugs. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483958por Mercedes Perez-Rodriguez, M, Rosell, Daniel, Moeller, Scott, Kundu, Prantik, McCLure, Margaret, Hazlett, Erin, New, Antonia“…METHODS: Study 1: We performed a randomized, double blind, placebo-controlled trial of DAR-0100A (15 mg/150 ml of normal saline i.v. over 30 min) in medication-free SPD patients (n=16). Study 2: Subjects: 15 SPD patients, 15 healthy controls [HC], and 15 psychiatric controls (PC). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483959por Silverstein, Steven, Demmin, Docia, Erickson, Molly, Thompson, Judy, Paterno, Danielle, Netser, Roni“…METHODS: We have assessed 25 patients with schizophrenia and 25 controls who are free of medical comorbidity with fERG and measures of visual function and symptom severity, and data collection is ongoing with patients and controls with diabetes and/or hypertension using these same measures. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
483960por Chabala, Chishala, Turkova, Anna, Thomason, Margaret J., Wobudeya, Eric, Hissar, Syed, Mave, Vidya, van der Zalm, Marieke, Palmer, Megan, Kapasa, Monica, Bhavani, Perumal K., Balaji, Sarath, Raichur, Priyanka A., Demers, Anne-Marie, Hoddinott, Graeme, Owen-Powell, Ellen, Kinikar, Aarti, Musoke, Philippa, Mulenga, Veronica, Aarnoutse, Rob, McIlleron, Helen, Hesseling, Anneke, Crook, Angela M., Cotton, Mark, Gibb, Diana M.“…The primary efficacy and safety endpoints are TB disease-free survival 72 weeks post randomisation and grade 3 or 4 adverse events. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto